PharmGKB Blog
Thursday, October 1, 2020

CPIC releases updated Genes-Drugs list

›
Clinical Pharmacogenetics Implementation Consortium (CPIC) has posted an updated Genes-Drug list . Changes include:  1. A new column was a...
Tuesday, September 29, 2020

PharmGKB tutorial for pharmacogenomics of drugs potentially used in the context of COVID-19

›
The PharmGKB tutorial for pharmacogenomics of drugs potentially used in the context of COVID-19 is now published in  Clinical Pharmacology a...
Wednesday, September 23, 2020

PharmCAT grant awarded

›
The co-PIs of the Pharmacogenomics Clinical Annotation Tool ( PharmCAT ). Dr. Marylyn Ritchie of the University of Pennsylvania and Dr. Teri...
Tuesday, September 8, 2020

CPIC Guideline update: HLA-B/CYP2C9 and Phenytoin/Fosphenytoin

›
The 2020  CPIC Guideline update for HLA-B ,  CYP2C19  and phenytoin dosing  is now published in  Clinical Pharmacology and Therapeutics .  T...
Wednesday, August 26, 2020

PharmGKB and CPIC Partner with ClinGen

›
PharmGKB and CPIC have formalized a partnership with ClinGen to bring pharmacogenomics (PGx) expertise to the primarily disease-focused,...
Tuesday, August 11, 2020

New CPIC Guideline: CYP2C19 and Proton Pump Inhibitors (PPIs)

›
The CPIC Guideline for  CYP2C19  and proton pump inhibitor (PPI) dosing  is now published in Clinical Pharmacology and Therapeutics .  The a...
Monday, August 10, 2020

CYP3A5 released on PharmVar

›
PharmVar and PharmGKB are excited to announce that   CYP3A5   has been transitioned into the PharmVar database. Variation information has be...
‹
›
Home
View web version

Contributors

  • Caroline Thorn, Curator
  • Katrin Sangkuhl
  • Li Gong
  • Mark Woon
  • Mark Woon
  • Michelle Whirl-Carrillo, Director and Co-PI
  • Ryan Whaley, Technical Lead
  • Teri Klein, Co-PI PharmGKB, CPIC, PharmCAT & ClinGen
Powered by Blogger.